ROMOLI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 907
EU - Europa 456
AS - Asia 354
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.724
Nazione #
US - Stati Uniti d'America 907
IE - Irlanda 186
SG - Singapore 151
IT - Italia 118
HK - Hong Kong 73
CN - Cina 67
VN - Vietnam 43
RU - Federazione Russa 24
FR - Francia 22
GB - Regno Unito 17
DE - Germania 16
SE - Svezia 15
FI - Finlandia 14
NL - Olanda 11
UA - Ucraina 9
AT - Austria 8
CH - Svizzera 7
KR - Corea 5
JP - Giappone 4
CZ - Repubblica Ceca 3
PH - Filippine 3
AR - Argentina 2
CL - Cile 2
GR - Grecia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
EC - Ecuador 1
ES - Italia 1
EU - Europa 1
IN - India 1
KZ - Kazakistan 1
LT - Lituania 1
MN - Mongolia 1
PL - Polonia 1
UZ - Uzbekistan 1
Totale 1.724
Città #
Chandler 214
Dublin 183
Singapore 125
San Mateo 84
Hong Kong 73
Boardman 56
Altamura 45
Dong Ket 43
Santa Clara 42
Medford 38
Princeton 38
Lawrence 35
Des Moines 30
Andover 25
Beijing 25
Wilmington 25
Perugia 19
Los Angeles 14
San Paolo di Civitate 11
Ashburn 10
Dearborn 10
Helsinki 9
Redwood City 9
Ancona 8
Redmond 8
Saint Petersburg 8
Falls Church 7
Norwalk 7
Ann Arbor 6
Amsterdam 5
Lausanne 5
London 5
Seoul 5
Bologna 4
Cava de' Tirreni 4
Dallas 4
Houston 4
Moscow 4
Recanati 4
Rome 4
Cosenza 3
Den Haag 3
El Paso 3
Falkenstein 3
Guangzhou 3
Jesi 3
Nanning 3
Paris 3
Arlandastad 2
Brno 2
Dumaguete 2
Frankfurt Am Main 2
Holten 2
Jacksonville 2
Lappeenranta 2
Milan 2
Munich 2
Santiago 2
Tokyo 2
Adelaide 1
Almaty 1
Athens 1
Baku 1
Brussels 1
Chicago 1
City Of Industry 1
Clifton 1
Delhi 1
Dubai 1
Edinburgh 1
General Santos 1
Hefei 1
Incisa 1
Lebrija 1
Luoyang 1
Marano Di Napoli 1
Mejiro 1
Montespertoli 1
Nagold 1
Newark 1
Olomouc 1
Portland 1
Quito 1
San Diego 1
Shenzhen 1
Washington 1
Woodbridge 1
Totale 1.329
Nome #
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 73
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: A post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial 63
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 57
Dural arteriovenous fistulas and headache features: an observational study 56
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 56
A53T in a parkinsonian family: a clinical update of the SNCA phenotypes 55
O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events? 55
Sleep disorders and late-onset epilepsy of unknown origin: Understanding new trajectories to brain amyloidopathy 55
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events 53
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 53
Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study 51
Stopping onabotulinum treatment after the first two cycles might not be justified: Results of a real-life monocentric prospective study in chronic migraine 49
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study 49
Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts 47
Amyloid-β: a potential link between epilepsy and cognitive decline 47
Levodopa in parkinson’s disease: Current status and future developments 46
Magnetization transfer MRI in dementia disorders, Huntington's disease and parkinsonism 45
Clinical features and outcome of 6 new patients carrying de novoKCNB1gene mutations 45
Levodopa-responsive breathing discomfort in Parkinson’s disease patients 45
Liverpool Adverse Events Profile: Italian validation and predictive value for dropout from antiepileptic treatment in people with epilepsy 44
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort 43
Teaching Images in Headache: Thrombosis of Posterior Communicating Artery Aneurysm 43
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 42
P066. Migraine with aura in the locker room: 4 case reports 41
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 41
Late onset epilepsy and Alzheimer's disease: exploring the dual pathogenic role of amyloid-β 40
null 39
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy 37
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences 36
Genotype–phenotype correlation of F484L mutation in three Italian families with Thomsen myotonia 36
Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study 36
Reperfusion strategies in stroke due to isolated cervical internal carotid artery occlusion: systematic review and treatment comparison 34
Risk Factors for Intracerebral Hemorrhage in Patients with Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention 33
Long-term follow-up in pediatric patients with paroxysmal hypothermia (Shapiro's syndrome) 32
Prognostic factors in children with PRES and hematologic diseases 30
An unbalanced synaptic transmission: Cause or consequence of the amyloid oligomers neurotoxicity? 29
Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative Databases 29
Cognitive Decline Risk Stratification in People with Late-Onset Epilepsy of Unknown Etiology: An Electroencephalographic Connectivity and Graph Theory Pilot Study 28
Selective basal ganglia vulnerability to energy deprivation: Experimental and clinical evidences 22
Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events? 21
Cardiovascular risk factors for epilepsy and dementia 17
Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy 16
null 13
The risk of stroke recurrence in patients with atrial fibrillation and reduced ejection fraction 11
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 9
Incidence and Risk Factors Epilepsy in Patients with Dementia: A Population-Based Study Using Regional Healthcare Databases in Umbria 8
Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study 3
Totale 1.813
Categoria #
all - tutte 10.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.241


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202066 0 0 0 0 0 10 7 18 2 20 5 4
2020/2021151 0 4 0 0 60 5 6 26 0 6 1 43
2021/2022278 2 69 1 0 12 6 3 84 17 6 38 40
2022/2023696 38 146 13 42 56 83 0 27 253 8 15 15
2023/2024296 16 37 14 11 6 4 59 11 11 13 59 55
2024/2025276 11 49 40 54 50 72 0 0 0 0 0 0
Totale 1.813